Literature DB >> 29544022

The Deletion of Hdac4 in Mouse Osteoblasts Influences Both Catabolic and Anabolic Effects in Bone.

Teruyo Nakatani1, Tiffany Chen1, Joshua Johnson1, Jennifer J Westendorf2, Nicola C Partridge1.   

Abstract

Histone deacetylase 4 (Hdac4) is known to control chondrocyte hypertrophy and bone formation. We have previously shown that parathyroid hormone (PTH) regulates many aspects of Hdac4 function in osteoblastic cells in vitro; however, in vivo confirmation was previously precluded by preweaning lethality of the Hdac4-deficient mice. To analyze the function of Hdac4 in bone in mature animals, we generated mice with osteoblast lineage-specific knockout of Hdac4 (Hdac4ob-/- ) by crossing transgenic mice expressing Cre recombinase under the control of a 2.3-kb fragment of the Col1a1 promoter with mice bearing loxP-Hdac4. The Hdac4ob-/- mice survive to adulthood and developed a mild skeletal phenotype. At age 12 weeks, they had short, irregularly shaped and stiff tails due to smaller tail vertebrae, with almost no growth plates. The tibial growth plate zone was also thinned, and Mmp13 and Sost mRNAs were increased in the distal femurs of Hdac4ob-/- mice. Immunohistochemistry showed that sclerostin was elevated in Hdac4ob-/- mice, suggesting that Hdac4 inhibits its gene and protein expression. To determine the effect of PTH in these mice, hPTH (1-34) or saline were delivered for 14 days with subcutaneously implanted devices in 8-week-old female Hdac4ob-/- and wild-type (Hdac4fl/fl ) mice. Serum CTX, a marker of bone resorption, was increased in Hdac4ob-/- mice with or without PTH treatment. Tibial cortical bone volume/total volume (BV/TV), cortical thickness (Ct.Th), and relative cortical area (RCA) were decreased in Hdac4ob-/- mice, but PTH caused no further decrease in Hdac4ob-/- mice. Tibial trabecular BV/TV and thickness were not changed significantly in Hdac4ob-/- mice but decreased with PTH treatment. These results indicate that Hdac4 inhibits bone resorption and has anabolic effects via inhibiting Mmp13 and Sost/sclerostin expression. Hdac4 influences cortical bone mass and thickness and knockout of Hdac4 prevents the catabolic effect of PTH in cortical bone.
© 2018 American Society for Bone and Mineral Research. © 2018 American Society for Bone and Mineral Research.

Entities:  

Keywords:  CATABOLIC EFFECTS OF PTH; CORTICAL BONE; HDAC4; OSTEOBLASTS; SCLEROSTIN

Mesh:

Substances:

Year:  2018        PMID: 29544022      PMCID: PMC6457245          DOI: 10.1002/jbmr.3422

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  40 in total

Review 1.  Catabolic and anabolic actions of parathyroid hormone on the skeleton.

Authors:  B C Silva; A G Costa; N E Cusano; S Kousteni; J P Bilezikian
Journal:  J Endocrinol Invest       Date:  2011-09-23       Impact factor: 4.256

Review 2.  Histone deacetylases in skeletal development and bone mass maintenance.

Authors:  Meghan E McGee-Lawrence; Jennifer J Westendorf
Journal:  Gene       Date:  2010-12-22       Impact factor: 3.688

3.  Control of the SOST bone enhancer by PTH using MEF2 transcription factors.

Authors:  Olivier Leupin; Ina Kramer; Nicole M Collette; Gabriela G Loots; François Natt; Michaela Kneissel; Hansjoerg Keller
Journal:  J Bone Miner Res       Date:  2007-12       Impact factor: 6.741

4.  Intracortical remodelling and porosity in the distal radius and post-mortem femurs of women: a cross-sectional study.

Authors:  Roger M D Zebaze; Ali Ghasem-Zadeh; Ann Bohte; Sandra Iuliano-Burns; Michiko Mirams; Roger Ian Price; Eleanor J Mackie; Ego Seeman
Journal:  Lancet       Date:  2010-05-15       Impact factor: 79.321

5.  Parathyroid hormone regulates the rat collagenase-3 promoter in osteoblastic cells through the cooperative interaction of the activator protein-1 site and the runt domain binding sequence.

Authors:  N Selvamurugan; W Y Chou; A T Pearman; M R Pulumati; N C Partridge
Journal:  J Biol Chem       Date:  1998-04-24       Impact factor: 5.157

6.  Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis.

Authors:  T Bellido; A A Ali; I Gubrij; L I Plotkin; Q Fu; C A O'Brien; S C Manolagas; R L Jilka
Journal:  Endocrinology       Date:  2005-08-04       Impact factor: 4.736

7.  HDAC5 controls MEF2C-driven sclerostin expression in osteocytes.

Authors:  Marc N Wein; Jordan Spatz; Shigeki Nishimori; John Doench; David Root; Philip Babij; Kenichi Nagano; Roland Baron; Daniel Brooks; Mary Bouxsein; Paola Divieti Pajevic; Henry M Kronenberg
Journal:  J Bone Miner Res       Date:  2015-03       Impact factor: 6.741

8.  Bone morphogenetic protein-2 stimulates Runx2 acetylation.

Authors:  Eun-Joo Jeon; Kwang-Youl Lee; Nam-Sook Choi; Mi-Hye Lee; Hyun-Nam Kim; Yun-Hye Jin; Hyun-Mo Ryoo; Je-Yong Choi; Minoru Yoshida; Norikazu Nishino; Byung-Chul Oh; Kyeong-Sook Lee; Yong Hee Lee; Suk-Chul Bae
Journal:  J Biol Chem       Date:  2006-04-13       Impact factor: 5.157

Review 9.  Parathyroid hormone: a double-edged sword for bone metabolism.

Authors:  Ling Qin; Liza J Raggatt; Nicola C Partridge
Journal:  Trends Endocrinol Metab       Date:  2004-03       Impact factor: 12.015

10.  SIKs control osteocyte responses to parathyroid hormone.

Authors:  Marc N Wein; Yanke Liang; Olga Goransson; Thomas B Sundberg; Jinhua Wang; Elizabeth A Williams; Maureen J O'Meara; Nicolas Govea; Belinda Beqo; Shigeki Nishimori; Kenichi Nagano; Daniel J Brooks; Janaina S Martins; Braden Corbin; Anthony Anselmo; Ruslan Sadreyev; Joy Y Wu; Kei Sakamoto; Marc Foretz; Ramnik J Xavier; Roland Baron; Mary L Bouxsein; Thomas J Gardella; Paola Divieti-Pajevic; Nathanael S Gray; Henry M Kronenberg
Journal:  Nat Commun       Date:  2016-10-19       Impact factor: 14.919

View more
  5 in total

1.  Abaloparatide at the Same Dose Has the Same Effects on Bone as PTH (1-34) in Mice.

Authors:  Carole Le Henaff; Florante Ricarte; Brandon Finnie; Zhiming He; Joshua Johnson; Johanna Warshaw; Victoria Kolupaeva; Nicola C Partridge
Journal:  J Bone Miner Res       Date:  2019-12-27       Impact factor: 6.741

2.  Hdac4 Regulates the Proliferation of Neural Crest-Derived Osteoblasts During Murine Craniofacial Development.

Authors:  Nayoung Ha; Jian Sun; Qian Bian; Dandan Wu; Xudong Wang
Journal:  Front Physiol       Date:  2022-02-15       Impact factor: 4.566

3.  Osteoblastic monocyte chemoattractant protein-1 (MCP-1) mediation of parathyroid hormone's anabolic actions in bone implicates TGF-β signaling.

Authors:  Jawed A Siddiqui; Carole Le Henaff; Joshua Johnson; Zhiming He; Daniel B Rifkin; Nicola C Partridge
Journal:  Bone       Date:  2020-11-17       Impact factor: 4.398

4.  Genome-wide association study implicates novel loci and reveals candidate effector genes for longitudinal pediatric bone accrual.

Authors:  Diana L Cousminer; Yadav Wagley; James A Pippin; Ahmed Elhakeem; Gregory P Way; Matthew C Pahl; Shana E McCormack; Alessandra Chesi; Jonathan A Mitchell; Joseph M Kindler; Denis Baird; April Hartley; Laura Howe; Heidi J Kalkwarf; Joan M Lappe; Sumei Lu; Michelle E Leonard; Matthew E Johnson; Hakon Hakonarson; Vicente Gilsanz; John A Shepherd; Sharon E Oberfield; Casey S Greene; Andrea Kelly; Deborah A Lawlor; Benjamin F Voight; Andrew D Wells; Babette S Zemel; Kurt D Hankenson; Struan F A Grant
Journal:  Genome Biol       Date:  2021-01-04       Impact factor: 13.583

Review 5.  Application of microRNA in Human Osteoporosis and Fragility Fracture: A Systemic Review of Literatures.

Authors:  Yen-Zung Wu; Hsuan-Ti Huang; Tsung-Lin Cheng; Yen-Mou Lu; Sung-Yen Lin; Cheng-Jung Ho; Tien-Ching Lee; Chia-Hao Hsu; Peng-Ju Huang; Han Hsiang Huang; Jhong-You Li; Yu-De Su; Shih-Chieh Chen; Lin Kang; Chung-Hwan Chen
Journal:  Int J Mol Sci       Date:  2021-05-15       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.